The detailed answer is available in the following course chapter:
(NOTE: this chapter is available for free preview)
Antipsychotics: Tardive Dyskinesias Management.
This chapter will be summarized in the following 9 sections:
Which medications are known to induce tardive dyskinesias after long term administration?
Which medical conditions can present with symptoms similar to tardive dyskinesias, and hence needs to be ruled out first?
How to clinically differentiate tardive dyskinesias from akathisia, parkinsonian tremors and acute dystonia?
Will you consider antipsychotic discontinuation in patient with tardive dyskinesias?
Switching to atypical antipsychotics are preferred, but which atypical antipsychotics will you choose?
If medications discontinuation/taper is not an option. What other medications can help this patient?
Will use of anticholinergic medications help with tardive dyskinesias?
Role of ECT (electroconvulsive therapy) or Pallidal deep brain stimulation for tardive dyskinesias.
Compare VMAT2 Inhibitors: Tetrabenazine, Valbenazine and Deutetrabenazine.
COMPARING VMAT2 INHIBITORS FOR TARDIVE DYSKINESIA:
SUBSCRIBE TO OUR:
PHYSICIAN’S GUIDE FOR CLINICAL PSYCHIATRY COURSE
- Total chapters= 250+ Chapters.
- Chapters and Sections are frequently updated.
- Each chapter includes references: with either pdf article or pubmed link for each article.
- Triweekly Email Clinical Summary: subscribers receive 3 emails/week.
- Goal: is to have all important clinically relevant topics in one course.
- Annual Subscription of $65/year: for continued access to course on an annual basis.